Nektar Therapeutics (NKTR) Financials

$74.19

$-2.18 (-2.85%)

As on 04-Sep-2026 16:01EDT

Market cap

$2,533 Mln

Revenue (TTM)

$55 Mln

P/E Ratio

--

P/B Ratio

2.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	54.59	55.23	98.43	90.12	92.06	101.91
Cost of Revenue	0.35	--	30.69	36.64	21.64	24.90
Gross Profit	54.24	55.23	67.74	53.48	70.42	77.01
Operating Expenses	185.46	186.00	172.94	190.90	310.66	523.11
Operating Profit (EBIT)	-131.22	-130.77	-105.20	-137.43	-240.24	-446.10
Other Income	--	--	--	--	--	-29.86
Profit before Tax	-156.74	-164.21	-119.20	-276.26	-364.98	-523.28
Provision for Tax	0.06	-0.14	-0.24	-0.20	3.22	0.56
Profit after Tax (Net Income)	-157.13	-164.08	-118.96	-276.06	-368.20	-523.84
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-368.20	-523.84

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	903.12	89.83	60.74	130.99	366.64	679.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	121.02	137.04	181.71	215.78	275.76	352.48
Current Liabilities	70.99	53.54	61.40	51.27	68.20	85.20
Total Liabilities	1,166.11	280.41	303.85	398.03	710.60	1,117.19

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	355.73	14.14	42.56	67.33	164.63	321.61
Current Assets	739.40	266.27	261.29	330.70	545.97	795.58
Total Assets	1,166.11	280.41	303.85	398.03	710.60	1,117.19
Total Debt*	135.93	148.91	102.56	117.78	131.50	143.18
Net Current Assets	668.42	212.73	199.89	279.43	477.76	710.38

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-208.51	-175.71	-192.61	-304.01	-412.66
Cash Flow from Investing Activities	--	-1.20	142.57	139.56	365.84	202.78
Cash from Financing Activities	--	180.57	42.12	0.03	1.51	36.24
Net Cash Inflow / Outflow	--	--	--	--	--	-173.65

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-7.34	-8.08	-8.35	-21.68	-29.34	-42.48
Cash EPS ($)	--	-8.03	-8.05	-20.94	-28.30	-41.33
Adjusted Book Value ($)	--	4.43	4.27	10.28	29.22	55.11
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-10.27	-12.34	-15.12	-24.23	-33.47
Free Cash Flow per Share ($)	--	-10.28	-12.44	-15.19	-24.68	-34.68

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-81.62	-57.74	-73.92	-55.75	-51.10
ROE (%)	-31.65	-217.94	-124.10	-110.95	-70.39	-59.64
ROA (%)	-21.75	-56.17	-33.90	-49.80	-40.29	-39.45
EBIT Margin (%)	-169.79	-249.91	-92.54	-278.42	-365.08	-467.06
Net Margin (%)	-287.84	-297.07	-120.86	-306.31	-399.98	-727.12
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-27.15	-0.44	0.09	-0.02	-0.10	-0.33
EBIT Growth (%)	-3.83	-51.53	63.70	25.34	29.39	-16.99
Net Profit Growth (%)	-28.51	-37.92	56.91	25.03	29.71	-17.86
EPS Growth (%)	15.76	0.03	0.61	0.26	0.31	-0.14
Book Value Growth (%)	1,689.74	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.23	-0.11	-0.03	-0.08	-0.32
Price / Book Value	2.75	9.55	0.22	0.05	0.08	0.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.50	-5.56	1.61	0.74	1.07	0.92
Close Price ($)	69.81	42.28	13.95	8.40	33.90	202.65
High Price ($)	109.00	66.92	28.92	47.85	214.80	401.25
Low Price ($)	21.02	6.48	7.20	6.15	29.85	158.85
Market Cap ($ Cr)	2,533.07	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	1.66	1.69	0.90	0.36	0.21
Short term debt to equity ratio	0.03	0.23	0.33	0.15	0.05	0.03
Current Ratio	10.42	4.97	4.26	6.45	8.00	9.34
Quick Ratio	10.42	--	4.26	6.14	7.72	9.15
Interest Coverage	-4.06	-5.27	-3.24	-9.90	-11.62	-10.06

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	8.71	3.22	1.63	2.50	9.13	22.07
Asset Turnover	0.08	0.19	0.28	0.16	0.10	0.08
Receivable days	--	11.20	7.16	21.59	61.29	110.00
Inventory Days	--	--	95.82	175.94	295.47	228.07
Payable days	--	--	127.41	113.77	191.84	233.89
Cash Conversion Cycle	--	--	-24.42	83.77	164.92	104.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.